-
U.
Ekman,
J.
Eriksson,
L.
Forsgren,
S.
Mo,
K.
Riklund,
L.
Nyberg
(2012)
Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study
The Lancet Neurology, 11
-
K.
Leenders,
E.
Salmon,
P.
Tyrrell,
D.
Perani,
D.
Brooks,
H.
Sager,
T.
Jones,
C.
Marsden,
Richard
Frackowiak
(1990)
The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.
Archives of neurology, 47 12
-
(2004)
On the use of PROC MIXED to estimate correlation in the presence of repeated measures
-
P.
Barone
(2010)
Neurotransmission in Parkinson’s disease: beyond dopamine
European Journal of Neurology, 17
-
C.
Harada,
Marissa
Love,
K.
Triebel
(2013)
Normal cognitive aging.
Clinics in geriatric medicine, 29 4
-
P.
Reuter-Lorenz,
J.
Jonides,
Edward
Smith,
A.
Hartley,
Andrea
Miller,
Christy
Marshuetz,
R.
Koeppe
(2000)
Age Differences in the Frontal Lateralization of Verbal and Spatial Working Memory Revealed by PET
Journal of Cognitive Neuroscience, 12
-
(2014)
Hypothesis tests for comparing correlations
-
I.
Litvan,
D.
Aarsland,
C.
Adler,
J.
Goldman,
J.
Kulisevsky,
B.
Mollenhauer,
M.
Rodriguez-Oroz,
A.
Tröster,
D.
Weintraub
(2011)
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
Movement Disorders, 26
-
G.
Spalletta,
R.
Robinson,
L.
Cravello,
F.
Pontieri,
M.
Pierantozzi,
A.
Stefani,
J.
Long,
C.
Caltagirone,
F.
Assogna
(2014)
The early course of affective and cognitive symptoms in de novo patients with Parkinson’s disease
Journal of Neurology, 261
-
(2003)
Prevalence and characteristics of dementia in Parkinson Disease
, 60
-
P.
Remy,
M.
Doder,
A.
Lees,
N.
Turjanski,
D.
Brooks
(2005)
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.
Brain : a journal of neurology, 128 Pt 6
-
D.
Weintraub,
A.
Newberg,
M.
Cary,
A.
Siderowf,
P.
Moberg,
G.
Kleiner‐Fisman,
J.
Duda,
M.
Stern,
D.
Mozley,
I.
Katz
(2005)
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 46 2
-
L.
Nyberg,
Nina
Karalija,
Alireza
Salami,
M.
Andersson,
A.
Wåhlin,
Neda
Kaboovand,
Ylva
Köhncke,
J.
Axelsson,
A.
Rieckmann,
G.
Papenberg,
D.
Garrett,
K.
Riklund,
M.
Lövdén,
U.
Lindenberger,
L.
Bäckman
(2016)
Dopamine D2 receptor availability is linked to hippocampal–caudate functional connectivity and episodic memory
Proceedings of the National Academy of Sciences, 113
-
C.
Caspell-Garcia,
T.
Simuni,
D.
Tosun-Turgut,
I-Wei
Wu,
Yu.
Zhang,
M.
Nalls,
A.
Singleton,
L.
Shaw,
Ju-Hee
Kang,
J.
Trojanowski,
A.
Siderowf,
C.
Coffey,
Shirley
Lasch,
D.
Aarsland,
D.
Burn,
L.
Chahine,
A.
Espay,
Eric
Foster,
K.
Hawkins,
I.
Litvan,
I.
Richard,
D.
Weintraub
(2017)
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
PLoS ONE, 12
-
Tao
Xie,
Peter
Warnke,
U.
Kang,
R.
Fuente-Fernández
(2012)
Role of DaTSCAN and clinical diagnosis in Parkinson disease
Neurology, 79
-
A.
Brück,
R.
Portin,
A.
Lindell,
A.
Laihinen,
J.
Bergman,
M.
Haaparanta,
O.
Solin,
J.
Rinne
(2001)
Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus
Neuroscience Letters, 311
-
D.
Gallagher,
A.
Lees,
A.
Schrag
(2010)
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
Movement Disorders, 25
-
R.
Weil,
T.
Lashley,
J.
Bras,
A.
Schrag,
J.
Schott
(2017)
Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies
F1000Research, 6
-
S.
Rutten,
Peter
Ven,
D.
Weintraub,
G.
Pontone,
A.
Leentjens,
H.
Berendse,
Y.
Werf,
O.
Heuvel
(2017)
Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.
Parkinsonism & related disorders, 43
-
K.
Marek,
D.
Jennings,
Shirley
Lasch,
A.
Siderowf,
C.
Tanner,
T.
Simuni,
Chris
Coffey,
K.
Kieburtz,
Emily
Flagg,
Sohini
Chowdhury,
W.
Poewe,
B.
Mollenhauer,
P.
Klinik,
T.
Sherer,
M.
Frasier,
C.
Meunier,
A.
Rudolph,
C.
Casaceli,
J.
Seibyl,
S.
Mendick,
N.
Schuff,
Ying
Zhang,
A.
Toga,
K.
Crawford,
Alison
Ansbach,
P.
Blasio,
Michele
Piovella,
J.
Trojanowski,
L.
Shaw,
A.
Singleton,
K.
Hawkins,
J.
Eberling,
D.
Brooks,
D.
Russell,
Laura
Leary,
S.
Factor,
B.
Sommerfeld,
P.
Hogarth,
E.
Pighetti,
Karen
Williams,
D.
Standaert,
Stephanie
Guthrie,
R.
Hauser,
H.
Delgado,
J.
Jankovic,
C.
Hunter,
M.
Stern,
B.
Tran,
J.
Leverenz,
Marne
Baca,
S.
Frank,
Cathi
Thomas,
I.
Richard,
C.
Deeley,
L.
Rees,
F.
Sprenger,
Elisabeth
Lang,
H.
Shill,
Sanja
Obradov,
Hubert
Fernandez,
Adrienna
Winters,
D.
Berg,
K.
Gauss,
D.
Galasko,
D.
Fontaine,
Z.
Mari,
M.
Gerstenhaber,
D.
Brooks,
Sophie
Malloy,
P.
Barone,
K.
Longo,
Tom
Comery,
B.
Ravina,
I.
Grachev,
Kim
Gallagher,
Michelle
Collins,
K.
Widnell,
Suzanne
Ostrowizki,
P.
Fontoura,
Tony
Ho,
J.
Luthman,
M.
Brug,
A.
Reith,
Peggy
Taylor
(2011)
The Parkinson Progression Marker Initiative (PPMI)
Progress in Neurobiology, 95
-
R.
Erro,
S.
Pappatà,
M.
Amboni,
C.
Vicidomini,
K.
Longo,
G.
Santangelo,
M.
Picillo,
C.
Vitale,
M.
Moccia,
Flavio
Giordano,
A.
Brunetti,
M.
Pellecchia,
M.
Salvatore,
P.
Barone
(2012)
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Parkinsonism & related disorders, 18 9
-
Vanessa
Cropley,
M.
Fujita,
R.
Innis,
P.
Nathan
(2006)
Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function
Biological Psychiatry, 59
-
G.
Tissingh,
P.
Bergmans,
J.
Booij,
A.
Winogrodzka,
E.
Royen,
J.
Stoof,
E.
Wolters
(1997)
Drug-naive patients with Parkinson’s disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]β-CIT SPECT
Journal of Neurology, 245
-
Francesco
Brigo,
A.
Matinella,
R.
Erro,
M.
Tinazzi
(2014)
[¹²³I]FP‐CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug‐induced parkinsonisms: a meta‐analysis
European Journal of Neurology, 21
-
R.
Fuente-Fernández,
K.
Lövblad
(2014)
DaTscan and Parkinson's disease: DAT binding should not lead to binding decisions in clinical practice
European Journal of Neurology, 21
-
R.
Djaldetti,
I.
Ziv,
E.
Melamed
(2006)
The mystery of motor asymmetry in Parkinson's disease
The Lancet Neurology, 5
-
D.
Aarsland,
K.
Andersen,
J.
Larsen,
A.
Lolk,
P.
Kragh‐Sørensen
(2003)
Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.
Archives of neurology, 60 3
-
A.
Rana,
H.
Ansari,
Abdul
Qureshi,
Eraad
Rahman
(2018)
Impact of Progression of Parkinson's Disease and Various Other Factors on Generalized Anxiety Disorder
Journal of Neurosciences in Rural Practice, 9
-
M.
Broen,
A.
Leentjens,
J.
Hinkle,
A.
Moonen,
M.
Kuijf,
N.
Fischer,
K.
Perepezko,
A.
Bakker,
G.
Pontone
(2018)
Clinical Markers of Anxiety Subtypes in Parkinson Disease
Journal of Geriatric Psychiatry and Neurology, 31
-
A.
Leentjens,
K.
Dujardin,
L.
Marsh,
P.
Martínez-Martín,
I.
Richard,
S.
Starkstein
(2011)
Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study
Movement Disorders, 26
-
Pekka
Jokinen,
A.
Brück,
S.
Aalto,
S.
Forsback,
R.
Parkkola,
J.
Rinne
(2009)
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.
Parkinsonism & related disorders, 15 2
-
J.
Goldman,
R.
Postuma
(2014)
Premotor and nonmotor features of Parkinson's disease.
Current opinion in neurology, 27 4
-
Nele
Verreyt,
G.
Nys,
P.
Santens,
G.
Vingerhoets
(2011)
Cognitive Differences Between Patients with Left-sided and Right-sided Parkinson’s Disease. A Review
Neuropsychology Review, 21
-
N.
Sawamoto,
M.
Honda,
T.
Hanakawa,
T.
Aso,
M.
Inoue,
H.
Toyoda,
Koichi
Ishizu,
H.
Fukuyama,
H.
Shibasaki
(2007)
Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum
Neurology, 68
-
S.
Chung,
H.
Yoo,
Jungsu
Oh,
Jae
Kim,
B.
Ye,
Y.
Sohn,
P.
Lee
(2018)
Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Parkinsonism & related disorders, 51
-
N.
Bajaj,
R.
Hauser,
I.
Grachev
(2013)
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
Journal of Neurology, Neurosurgery, and Psychiatry, 84